EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Global disparities in cancer care: Bridging the gap in affordability and access to medications between high and low‐income countries

Arafat H Tfayli iD, Laura N El-Halabi, Fadlo R Khuri

Cancer · 2025-01 · 131 (1)

DOI: 10.1002/cncr.35590 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancer, online erschienen am 18.11.2024. Verfasst von Arafat H Tfayli und 2 weiteren Autor:innen. Beteiligte Einrichtung: Naef K. Basile Cancer Institute, Division of Hematology/Oncology, American University of Beirut Medical Center, Beirut, Lebanon. Hauptthemen laut MEDLINE: Neoplasms, Developing Countries, Health Services Accessibility, Healthcare Disparities. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 39 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cancer remains a significant challenge for health care systems, despite notable progress in the field. These advancements have significant financial implications that disproportionately affect low‐income countries. This review article aims to explore the present state of drug development, assessing the availability of drugs in different income countries, and proposing potential solutions to address the inequality in access to new cancer treatments.

Methods

A search was conducted on MEDLINE and PubMed on October 2, 2023 and updated on December 14, 2023, limited to English language articles.

Results

There is a projected rise in cancer cases worldwide, particularly in low‐income countries where most cancer‐related deaths are expected. Although the approval rate of cancer treatments has risen, their excessive cost and lack of affordability pose significant barriers to widespread access. Disparities in the costs of crucial cancer medications are influenced by geographic location and procurement connections. Potential solutions to address the inequity in drug distribution include sharing production secrets, implementing price discrimination, international funding, improved primary health care measures, and the implementation of cost‐effective screening methods.

Conclusion

Preventing, screening for, and treating cancer should be a global priority with minimal differences in access to therapy among various countries.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsDeveloping CountriesHealth Services AccessibilityHealthcare DisparitiesHumansAntineoplastic AgentsDeveloped CountriesGlobal HealthDrug Costs

Stichwörter der Autor:innen

accessibilityaffordabilitycancer therapyinequitylow‐income countries

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • Naef K. Basile Cancer Institute, Division of Hematology/Oncology, American University of Beirut Medical Center, Beirut, Lebanon.

ORCID-Profile: Arafat H Tfayli

Zitieren

APA

Tfayli, A. H., El-Halabi, L. N., & Khuri, F. R. (2025). Global disparities in cancer care: Bridging the gap in affordability and access to medications between high and low‐income countries. Cancer, 131(1). https://doi.org/10.1002/cncr.35590

Vancouver

Tfayli AH, El-Halabi LN, Khuri FR. Global disparities in cancer care: Bridging the gap in affordability and access to medications between high and low‐income countries. Cancer. 2025;131(1). doi:10.1002/cncr.35590

BibTeX
@article{Tfayli2025,
  author = {Tfayli, Arafat H and El-Halabi, Laura N and Khuri, Fadlo R},
  title = {Global disparities in cancer care: Bridging the gap in affordability and access to medications between high and low‐income countries},
  journal = {Cancer},
  year = {2025},
  volume = {131},
  number = {1},
  doi = {10.1002/cncr.35590}
}
Kostenlos starten →